First-in-human phase 1 single-dose study of TRX-518, an anti-human glucocorticoid-induced tumor necrosis factor receptor (GITR) monoclonal antibody in adults with advanced solid tumors Meeting Abstract

  

Authors:	Koon, H. B.; Shepard, D. R.; Merghoub, T.; Schaer, D. A.; Sirard, C. A.; Wolchok, J. D.
Abstract Title:	First-in-human phase 1 single-dose study of TRX-518, an anti-human glucocorticoid-induced tumor necrosis factor receptor (GITR) monoclonal antibody in adults with advanced solid tumors
Meeting Title:	52nd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	34
Issue:	15 Suppl.
Meeting Dates:	2016 Jun 3-7
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2016-05-20
Start Page:	146s
Language:	English
ACCESSION:	WOS:000404665404056
DOI:	10.1200/JCO.2016.34.15_suppl.3017
PROVIDER:	wos
Notes:	Meeting Abstract: 3017 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/154989